Canada’s October Inflation Cools Slightly, Giving the Bank of Canada More Policy Room
Canada’s October CPI undershot forecasts, but a stronger monthly core reading keeps the inflation picture mixed for the Bank of Canada and markets.
Quebecor’s C$31 Billion Telus Bid Puts Canadian Telecom Competition in Focus
Quebecor’s C$31 billion offer for Telus could reshape Canadian telecom competition, with regulatory …
Ameris Bancorp Expands in Central Florida With Bank of Central Florida Acquisition
Ameris Bancorp’s Lakeland deal underscores how regional banks are using Central Florida and broader …
Canadian Natural Resources’ $1.7 Billion Advantage Energy Deal Extends Canadian Oil and Gas Consolidation
CNQ’s $1.7 billion Advantage Energy acquisition signals continued consolidation and highlights Canad…
Diamondback Energy’s $5 Billion Double Eagle Deal Signals Fresh Permian Consolidation
Diamondback Energy’s $5 billion Double Eagle acquisition gives FANG shares a fresh catalyst and rein…
Softer US PPI Eases Hawkish Fed Fears—but Inflation Relief Has Limits
A softer US PPI reading eased hawkish Fed fears and supported risk appetite, but officials still see…
Goldman Sachs Seeks a Second Payday From Anthropic’s IPO
Goldman Sachs is reportedly pursuing both underwriting fees and wealth-management business tied to A…
Go Residential’s Lawsuit Adds Legal Overhang for H&R REIT Shareholders
Go Residential is suing H&R REIT after shareholders rejected its acquisition offer, adding uncertain…
Cohere’s Cubic Acquisition Puts AI Cyber Defense at the Center of Consolidation
Cohere’s acquisition of Cubic signals how AI companies are moving into cybersecurity as enterprise a…
Viking Therapeutics Shares Gain as Renewed Takeover Interest Reignites Biotech M&A Speculation
Viking Therapeutics shares gained after renewed takeover-interest reports, putting biotech M&A premi…
Norfolk Southern–Union Pacific Merger Spread Widens as CEO Remarks Raise Deal Concerns
The widening Norfolk Southern–Union Pacific deal spread puts completion risk back at the center of t…
US Producer Prices Rise 6.5% in October, Keeping Fed Policy in Focus
October producer prices were slightly softer than forecast, but elevated inflation keeps Federal Res…
UniFirst-Cintas Deal Spread Widens as FTC 'Last Rites' Report Raises Antitrust Risk
A reported FTC “last rites” meeting has widened the UniFirst-Cintas deal spread, signaling higher ma…
Markets
- FTC Merger Challenge Puts $3.5 Billion Covetrus-MWI Deal Spread in Focus
- Hancock Whitney-Trustmark Deal Signals Fresh Wave of Regional Bank Consolidation
- Investcorp Credit Management BDC Surges More Than 50% on BCP Investment Merger Deal
- Installed Building Products’ $698 Million Old Dominion Deal Puts Sector Consolidation in Focus
Economy
- Half-Point Fed Hike Risk Raises Stakes for U.S. Stocks, Bonds and Housing
- Hot Inflation Data Sends Mortgage Rates Higher as Wall Street Rate-Cut Hopes Fade
- Retail Sales Growth Slows to Nearly One-Year Low as Consumer Strain Builds
- Reuters Poll Points to Another Fed Rate Hike as Inflation Risks Persist
Analysis
- Airbnb Shares Rise 5.64% as Golden Cross Signals Renewed Technical Momentum
- Donchian Channel Breakout: 10-Year ETF Backtest
- MACD vs Moving Average Crossover: 9-Year SPY, QQQ Test
- ADX Trend Strength: What 10 Years of ETF Data Show
Earnings
- Cisco Raises AI Infrastructure Stakes After Earnings Beat and Revenue-Doubling Forecast
- Cerebras Surges 13% After Revenue Beat and Microsoft Cloud Partnership
- Costco Announces Special Dividend as Shareholders Watch Holiday Payout
- JetBlue CEO Bets on Premium Strategy Despite Creditor Concerns
Technology
- Nvidia Shares Face New Pressure as Lutnick Agrees to Testify on China Chip Sales
- IBM’s AuthMind Acquisition Extends Its Push Into Cybersecurity
- Chip Stocks Rally Despite Nvidia Scandal as Traders Test a Potential Market Bottom
- Meta Executive’s Move to Fireworks Highlights Intensifying AI Talent War
IPO
- Anthropic IPO Filing Ignites Tech Rally While Founder Control Tests Investors
- TriGemX Bio’s $600 Million SPAC Merger Creates a New Nasdaq Biotech Watchlist Name
- XTEND AI Robotics: Analyzing the Market Implications of Its NYSE Debut
- Werewolf Therapeutics and Ambros' Merger: A New Era in Biotech
